CME/CE: Conference Highlights – CHEST 2016

CME/CE: Conference Highlights – CHEST 2016
Target Audience (click to view)

This activity is designed to meet the needs of physicians and nurses.

Learning Objectives(click to view)

Upon completion of the educational activity, participants should be able to:

 

  • Discuss the key findings of six studies presented at the 2016 annual international scientific assembly of the American College of Chest Physicians.

Method of Participation(click to view)

Release Date: 02/16/2017
Expiration Date: 02/16/2018

Statements of credit will be awarded based on the participant reviewing monograph, correctly answer 2 out of 3 questions on the post test, completing and submitting an activity evaluation.  A statement of credit will be available upon completion of an online evaluation/claimed credit form at http://akhcme.com/akhcme/lessons/42.  You must participate in the entire activity to receive credit.  If you have questions about this CME/CE activity, please contact AKH Inc. at dcotterman@akhcme.com.

Credit Available(click to view)

AKH

CME Credit Provided by AKH Inc., Advancing Knowledge in Healthcare

Physicians
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and Physician’s Weekly’s.  AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians.

AKH Inc., Advancing Knowledge in Healthcare designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants
NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME.

 

Nursing
AKH Inc., Advancing Knowledge in Healthcare is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity is awarded 0.5 contact hours.

Commercial Support(click to view)

There is no commercial support for this activity.

Disclosures(click to view)

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content; notification of independent and certified CME/CE expectations; referral to National Author Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other author for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review.

Disclosure of Unlabeled Use & Investigational Product(click to view)

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer(click to view)

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant’s misunderstanding of the content.

Faculty & Credentials(click to view)

Christopher Cole – Managing Editor
Discloses no financial relationships with pharmaceutical or medical product manufacturers.
AKH and PHYSICIAN WEEKLY’S STAFF/REVIEWERS

Dorothy Caputo, MA, BSN, RN- CE Director of Accreditation
Discloses no financial relationships with pharmaceutical or medical product manufacturers.

AKH planners and reviewers have no relevant financial relationships to disclose.

Share on FacebookTweet about this on TwitterShare on LinkedIn

 

New research was presented at CHEST 2016, the annual international scientific assembly of the American College of Chest Physicians, from October 22 to 26, 2016 in Los Angeles. The features below highlight some of the studies emerging from the conference.

Sleep & COPD Worsen Together

Prior research has linked poor sleep quality to reductions in health-related quality of life (QOL) among patients with COPD. To gain more insight into this relationship, researchers conducted a study in which patients with stable COPD and a mean age of 63 completed multiple questionnaires and pulmonary function tests. Patients were then categorized as having mild, moderate, or severe COPD. Quality of sleep was poor in all participants and worsened with COPD progression. The following patient factors were associated with decreasing QOL:

  • COPD severity.
  • Female gender.
  • Sleep quality.

Diagnosing Pulmonary Embolism With Bedside Ultrasound

Point-of-care ultrasound to test for pulmonary embolism (PE) is typically conducted by cardiologists, but these specialists are often unavailable. Time is of the essence when diagnosing and treating PE. A study sought to determine if pulmonary and critical care fellows could appropriately perform point-of-care ultrasounds for PE. Investigators asked fellows who attended a 30-day introductory course on this testing modality to evaluate right ventricular size and function at the bedside of 60 patients. Overall, their diagnostic accuracy was about 80%. Intensivists achieved accuracies higher than 90% in many cases. On average, point-of-care ultrasound was performed 1 day earlier than transthoracic echocardiogram in the analysis.

Bronchiecstasis Common in COPD

Previous research into the importance of bronchiectasis among patients with COPD has provided mixed results. For a study, investigators sought to better understand the incidence and impact of bronchiectasis in this patient population. Among nearly 900 patients with COPD, about 42% had radiologically proven bronchiectasis. Of patients who had experienced more than one COPD exacerbation in the previous year, nearly 93% had bronchiectasis. The authors also observed the following:

Stage of COPD Rate of Bronchiectasis
Stage 1 25%
Stage 2 36%
Stage 3 49%
Stage 4 59%

 

More E-Cigarette Research Needed

Evidence suggests that e-cigarette use is increasing throughout the United States, but data are lacking on their safety and relevance to traditional cigarette smoking cessation. Yale researchers conducted a survey to determine what healthcare providers told patients who inquired about using e-cigarettes for smoking cessation. Nearly 70% of providers reported that e-cigarettes were intrinsically harmful to human health. However, about one-third felt they were affective as smoking-cessation aids, one-third disagreed, and one-third had no opinion. With 88% of respondents reporting that patients ask about e-cigarettes, and 80% saying some patients use them specifically as cessation aides, more research is needed to understand their safety.

Home Visits Benefit COPD & Asthma Patients

Previous studies indicate that home visits may help increase compliance with an integrative disease management program for patients with severe asthma and COPD. For a study, researchers assessed healthcare utilization and patient adherence in the year prior to and after a single home visit. Patients were asked about why they missed scheduled office visits and assessed for asthma or COPD severity. In the year following the home visit, compliance with office visits increased significantly. In addition, intervention recipients had significantly fewer ED visits and significantly better adherence with maintenance inhalers.

 

Lung Biopsies & Pneumothorax Incidence

Evidence suggests that electromagnetic navigation allows for many procedures to be performed safely and with minimal invasiveness. However, data are lacking on the use of electromagnetic navigation in performing lung cancer biopsies. As part of an ongoing study, patients underwent lung biopsy using an electromagnetic navigation system. Participants had an average age of 67, more than 80% had a history of smoking or were current smokers, and 47% had COPD. Among the first 500 patients treated with the system, grade 2 or greater pneumothorax had an incidence rate of less than 3%. Electromagnetic navigation bronchoscopy-aided samples provided a diagnosis in 82% of patients.


 

NEWS FROM CHEST 2016

Low Rate of Pneumothorax With EM Navigation System

Once-Daily, Nebulized LAMA Shows Promise

Experts Debate: Do Sleep Labs Have a Future?

Arformoterol Safe in Combination With Tiotropium in COPD

Diffusion Capacity Testing Predicts COPD Exercise Capacity

Metformin in COPD Patients Improves Outcomes

Spirometry Underutilized in Primary Care

 

 

Submit a Comment

Your email address will not be published. Required fields are marked *

three × 2 =